Pharma News, 2016

OSAKA, Japan and FLORHAM PARK, NJ, USA I September 7, 2016 I Shionogi today presented positive results of a 52-week, placebo-controlled, phase III study (COMPOSE III) of naldemedine in treatin...

Widespread use of oral contraceptives has driven the fall in deaths from ovarian cancer worldwide, a major study has found.

Orion Corporation announced today that it has entered into a collaboration agreement with Menarini Group, for the co-marketing of budesonide-formoterol Easyhaler® combination product in Germany, Ital...

A revolutionary drug that melts away cancer in some stage four patients has been given fast-track approval in the United States.

The market for attention deficit hyperactivity disorder (ADHD) across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to experience an...

The use of the CRISPR-Cas9 genome editing system for the regulation of genes with the aim of rewiring cancer cells in vitro is reported in the journal Nature Methods.

German chemical and pharmaceutical company Bayer AG has raised the price on the purchase of the American manufacturer of herbicides and genetically modified seeds Monsanto up to $127,5.

Merck ($MRK) is giving up on its delayed and long-troubled bone drug odanacatib after it became apparent the safety risk from using the experimental med was just too high.

BRIGHTON, UK I September 5, 2016 I Destiny Pharma Ltd, a leading clinical stage biopharmaceutical company focused on developing antibacterial medicines, today announced the results of a US clinical tr...

Hillary Clinton said on Friday that if elected to the White House she would create an oversight panel to protect U.

From Zacks Research.

Netherlands-incorporated Mylan (Nasdaq.